Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Posts falsely claim Netanyahu video fabricated to cover up his death - 2U.S. overhauls childhood vaccine schedule, recommends fewer shots
- 375% of Arab Israelis support Arab party joining government coalition post-war, survey reveals
- 4Investigate Business Mastercard Choices for Better Rewards and Rewards
- 5Woman, 60, Is Finally Traveling the World Decades After Husband’s Death Held Her Back
- Fiber is something most people could use more of. But experts advise caution with 'fibermaxxing'
- 3 moms, 3 countries, 1 very familiar problem: Why child care costs still don't add up for families
- Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
- Flying without a Real ID? That'll soon cost you $45, TSA says.
- Study reveals links between global food systems, obesity, and climate change
- 3 astronauts settle into their new life in orbit | On the International Space Station this week Dec. 1-5, 2025
- Unwind: Four Extraordinary Spa Resorts On the planet
- Public Parks in the USA
- Culinary Joys: Investigating Connoisseur Cooking at Home
